Clinical Trial Update: A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Brenipatide (LY3537031) in healthy participants with obesity or overweight status is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Brenipatide (LY3537031) (LY3537031)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 1 | Status: RECRUITING